Avita Medical Inc (RCEL) – Company Profile and SWOT Analysis

Avita Medical Inc (RCEL) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. It develops products to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company’s lead product is RECELL System, a single-use (disposable) stand-alone, battery operated device, which is approved for the treatment of acute thermal burns in adult patients; and also for treating vitiligo and full-thickness skin defects in the US. The company has operations in the US, Australia, Japan and the UK, besides the European Union. Avita Medical is headquartered in Valencia, California, the US.

Scope

Detailed information on Avita Medical Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Avita Medical Inc in the form of a SWOT analysis

An in-depth view of the business model of Avita Medical Inc including a breakdown and examination of key business segments

News about Avita Medical Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Avita Medical Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Avita Medical Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Avita Medical Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Smith & Nephew Plc

Johnson & Johnson

Pfizer SA de CV

Organogenesis Holdings Inc

Vericel Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Avita Medical Inc - Key Facts

Avita Medical Inc - Key Employees

Avita Medical Inc - Key Employee Biographies

Avita Medical Inc - Major Products and Services

Avita Medical Inc - History

Avita Medical Inc - Company Statement

Avita Medical Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Avita Medical Inc - Business Description

Geographical Segment: Australia

Performance

Geographical Segment: European Union

Performance

Geographical Segment: Japan

Performance

Geographical Segment: United Kingdom

Performance

Geographical Segment: United States

Performance

R&D Overview

Avita Medical Inc - Corporate Strategy

Avita Medical Inc - SWOT Analysis

SWOT Analysis - Overview

Avita Medical Inc - Strengths

Avita Medical Inc - Weaknesses

Avita Medical Inc - Opportunities

Avita Medical Inc - Threats

Avita Medical Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Avita Medical Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025

Avita Medical Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025

Avita Medical Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 24, 2025: Avita Medical To Host Acute Wound Care Showcase on May 13, 2025

Feb 13, 2025: Avita Medical Releases Q4 and Full Year 2024 Results

Feb 13, 2025: AVITA Medical Reports Fourth Quarter and Full Year Financial Results for 2024

Jan 07, 2025: AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Aug 01, 2024: AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales

Jul 01, 2024: AVITA Medical Names Nicole Kelsey as Chief Legal and Compliance Officer and Corporate Secretary

Jul 01, 2024: AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

Apr 10, 2024: AVITA Medical Updates Expected First Quarter 2024 Revenue

Feb 22, 2024: AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

Jan 10, 2024: AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Avita Medical Inc, Key Facts

Avita Medical Inc, Key Employees

Avita Medical Inc, Key Employee Biographies

Avita Medical Inc, Major Products and Services

Avita Medical Inc, History

Avita Medical Inc, Other Locations

Avita Medical Inc, Subsidiaries

Avita Medical Inc, Joint Venture

Avita Medical Inc, Key Competitors

Avita Medical Inc, Ratios based on current share price

Avita Medical Inc, Annual Ratios

Avita Medical Inc, Annual Ratios (Cont…1)

Avita Medical Inc, Annual Ratios (Cont…2)

Avita Medical Inc, Interim Ratios

Avita Medical Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025

Avita Medical Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025

Avita Medical Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Avita Medical Inc, Performance Chart (2020 – 2024)

Avita Medical Inc, Ratio Charts

Avita Medical Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025

Avita Medical Inc, Medical Equipment, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports